Stock Analysis on Net

Edwards Lifesciences Corp. (NYSE:EW)

This company has been moved to the archive! The financial data has not been updated since February 14, 2022.

Income Statement 

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Edwards Lifesciences Corp., consolidated income statement

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Net sales 5,232,500 4,386,300 4,348,000 3,722,800 3,435,300
Cost of sales (1,248,900) (1,080,600) (1,114,400) (939,400) (875,300)
Gross profit 3,983,600 3,305,700 3,233,600 2,783,400 2,560,000
Selling, general, and administrative expenses (1,493,700) (1,228,400) (1,242,200) (1,088,500) (984,700)
Research and development expenses (903,100) (760,700) (752,700) (622,200) (552,600)
Intellectual property litigation income (expenses), net (20,600) (405,400) (33,400) (214,000) 73,300
Change in fair value of contingent consideration liabilities, net 124,100 (13,600) 6,100 5,700 9,900
Special charges (64,600) (116,200) (9,700)
Other operating expenses (700)
Operating income 1,690,300 897,600 1,146,800 748,200 1,095,500
Interest expense (18,400) (15,800) (20,700) (29,900) (23,200)
Interest income 17,400 23,400 32,200 32,000 20,300
Special gains (charges) 7,100 (50,200)
Foreign exchange gains (losses), net 5,000 12,300 5,900 6,700 (5,400)
Gain (loss) on investments 5,800 600 500 (1,700) (2,700)
Non-service cost components of net periodic pension benefit credit (cost) (300) (400) (200) 100
Other 2,200 (1,000) 2,000 (1,100) 600
Other income (expense), net 12,700 11,500 8,200 4,000 (7,500)
Income before provision for income taxes 1,702,000 916,700 1,166,500 761,400 1,034,900
Provision for income taxes (198,900) (93,300) (119,600) (39,200) (451,300)
Net income 1,503,100 823,400 1,046,900 722,200 583,600

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Income statement item Description The company
Net sales Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Edwards Lifesciences Corp. net sales increased from 2019 to 2020 and from 2020 to 2021.
Operating income The net result for the period of deducting operating expenses from operating revenues. Edwards Lifesciences Corp. operating income decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level.
Income before provision for income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Edwards Lifesciences Corp. income before provision for income taxes decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level.
Net income The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Edwards Lifesciences Corp. net income decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level.